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Long a slogan for environmentalists, ‘‘think global, act local’’ could be a new rallying cry for biolo-
gists. As genome-wide techniques advance and their costs drop, scientists are expanding into
larger and larger territories—metagenomics, global proteomic approaches, and analyses of thou-
sands of genomes. These massive data sets are opening up new possibilities for understanding
some of the smallest details of the genome. Here, we look at four such cases—investigating the
evolutionary role of insertions and deletions in the genome, connecting an orphan enzyme with
its gene, mapping the fine details of chromatin structure, and characterizing global interactions
between proteins and RNA—all of which depend on a combination of global thinking and local
action.A Genome-wide Strategy to Create High-Payoff Mutations
Genomic regions of structural variation, typically hundreds to thousands of base pair insertions and deletions, are frequently
associated with disease through unknown mechanisms. These areas do not occur randomly throughout the genome but
rather cluster together in ‘‘hot spots’’ of hypermutability. Previous studies in human cancer cells found that regions of hyper-
mutability often overlapped with regions of DNA hypomethylation. Now, a study by Li et al. (2012) combines these two obser-
vations and demonstrates that methylation deserts (stretches of DNA hypomethylation) in the germline demarcate hot spots
of structural variation, generating rapidly evolving regions of the genome. By analyzing the methylomes from four human
sperm samples, they find significant overlap between hypomethylation and recent structural variants, which were identified
through evolutionary and population genetic studies. Li et al. also examine samples from patients with various neurological
disorders associated with structural variation and demonstrate that DNA hypomethylation is significantly associated with the
etiological mutations. Li and colleagues postulate that the correlation between DNA hypomethylation and hypermutable
regions represents an epigenetic mechanism that has evolved to select areas of the genome that may generate potentially
beneficial mutations with a high pay-off; the regions susceptible to this process will necessarily also be high-risk regions,
and thus many mutations will lead to disease, but some will lead to significant gains in fitness. For example, genomic regions
related to brain development are likely candidates for this type of hypermutability. This hypothesis is supported by their finding
that methylation deserts are associated with de novo mutations causing schizophrenia, bipolar disorder, and autism. To
further test this hypothesis, however, the underlying mechanism for establishing these hot spots will need to be discovered.
Li, J., et al. (2012). PLoS Genet. 8, e1002692.Genomic neighbors of the pathway neighbors
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Genes for Orphan Enzymes
A sequenced genome may be the blueprint of an organism, but it often comes
up short in identifying the tools used to realize that blueprint—enzymes.
Orphan enzymes, which have known biochemical functions but unknown
genes, often represent crucial intermediate steps in metabolic pathways.
Identifying their genes is a necessary first step for metabolic engineering,
drug design, and proteomic approaches. Yamada et al. (2012) now develop
a computational approach to tackle this problem by using metabolic pathway
information about orphan enzymes and prokaryotic genomic and metage-
nomic sequences. Their algorithm relies on the observation that genes
involved in the same metabolic pathways are often physically close to one
another in prokaryotic genomes. This generates genomic neighborhoods
that can then be searched in more detail for the gene encoding the orphan enzyme. Yamada et al. validate their approach
by expressing candidate sequences, purifying the proteins, and testing them with the appropriate enzymatic assays. Their
method also predicts functions for protein domains of previously unknown functions. Finally, Yamada and colleagues
assess how their predicted genes alter global metabolic models. They find that many orphan enzymes represent new reac-
tions; this alters the predicted essentiality of certain genes in metabolic models. One drawback to this new approach is that
it requires an orphan enzyme to have some known pathway neighbors a priori. As more data become available from
genome-wide functional analyses, such as gene lethality screens, this limitation may be overcome through greater reliance
on genomic neighborhood information.
Yamada T., et al. (2012). Mol. Syst. Biol. 8, 581.Cell 149, June 22, 2012 ª2012 Elsevier Inc. 1413
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New techniques to determine the 3D structure of the genome, such as chro-
mosome conformation capture (3C) and Hi-C, have provided an increasingly
detailed picture of chromatin structure. Dixon et al. (2012) now take this
method to the next level with their comprehensive, high-resolution Hi-C
analysis of mouse embryonic stem cells (ESC), human ESC, and human fibro-
blasts. In all three cell types, more than 90% of the genome exists in self-
interacting regions of megabases, which they term topological domains. These
domains are conserved between cell types and species, suggesting that this
organization is a universal feature of metazoans. As expected, the boundaries
of these domains are enriched with CTCF, a factor known to bind to insulator
elements. However, the boundaries are also associated with other factors,
such as housekeeping genes and proteins found at active promoters and
gene bodies. These observations suggest that topological domains are gener-
ated, in part, by transcriptional activity. Interestingly, Dixon and colleagues
also find that high levels of the heterochromatin mark H3K9me3 were prevalent
in differentiated cells, forming large domains bounded by the topological
domain boundaries, but they do not observe this in ESC, implying that the
boundaries are established prior to the formation of heterochromatic regions
and may serve as guides for later chromatin changes. The functional signifi-
cance of this chromatin organization is still not well understood, and expand-ing this type of analysis to other cell types, including tumor cells, will help to determine the role of topological domains in
both normal cellular processes and disease states.
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Although new methods have been developed for large-scale characterization
of RNA-protein interactions, many of these approaches are time-consuming
and biased towards only the strongest interactions. Now, Campbell et al.
(2012) introduce a new method, SEQRS, which speeds up and refines the
global identification of protein-RNA interactions. SEQRS combines in vitro
selection, high-throughput sequencing, and bioinformatic analysis to compre-
hensively characterize protein-RNA-binding events. Applying SEQRS, Camp-
bell et al. find that the affinity of a protein for a particular RNA sequence can
be modified by the presence of a second protein, as has been shown for
DNA-protein interactions. They propose that some RNA-binding proteins
can exert their regulatory influence without binding RNA at all but rather by
modifying the interaction between a second protein and RNA. Campbell and
colleagues also use SEQRS to identify new RNA regulatory elements and quan-
titatively assess the relative strengths of binding to these motifs. Finally, they
apply their method to characterize possible off-target binding of RNA-binding
proteins engineered to recognize a novel RNA sequence and observe that
these designer proteins are highly specific, which is encouraging for the devel-
opment of RNA-binding proteins as therapeutic molecules. Ultimately, the
SEQRS results will need to be verified in vivo, but clearly this rapid, comprehen-
sive approach will serve as an excellent starting point for deeper investigations
into protein-RNA interactions.
Campbell Z., et al., (2012). Cell Rep. 1, 570–581.
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